VIRX
Viracta Therapeutics Inc
Price:  
0.17 
USD
Volume:  
2,469,004.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

VIRX WACC - Weighted Average Cost of Capital

The WACC of Viracta Therapeutics Inc (VIRX) is 5.7%.

The Cost of Equity of Viracta Therapeutics Inc (VIRX) is 13.80%.
The Cost of Debt of Viracta Therapeutics Inc (VIRX) is 5.00%.

Range Selected
Cost of equity 11.20% - 16.40% 13.80%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 5.2% - 6.2% 5.7%
WACC

VIRX WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 1.59 2.05
Additional risk adjustments 0.0% 0.5%
Cost of equity 11.20% 16.40%
Tax rate 26.20% 27.00%
Debt/Equity ratio 4.04 4.04
Cost of debt 5.00% 5.00%
After-tax WACC 5.2% 6.2%
Selected WACC 5.7%